Leona K.
- Country
- Czechia
- Department
- Pneumologická klinika 2.LF UK a FNMH, V Úvalu 84, 150 06 Praha 5
Research Overview
- Evaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study
- Tarlatamab plus Durvalumab versus Durvalumab Alone in Patients with Extensive-Stage Small Cell Lung Cancer Following Platinum-Etoposide Therapy
- Efficacy and Safety of PF-08634404 Plus Combination Therapy Versus Pembrolizumab Plus Combination Therapy in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 208 of 474 partner sites.
Specializations
Non-Small Cell Lung Cancer
The investigator specializes in treating various stages of non-small cell lung cancer (NSCLC), with particular focus on both early-stage and advanced disease states. Their expertise encompasses resectable and borderline resectable conditions from stages IB through IIIB.
- Early-stage NSCLC management
- Advanced and metastatic NSCLC treatment
- EGFR-mutated NSCLC therapy
The investigator works with innovative therapeutic approaches including immunotherapy combinations and targeted treatments for specific genetic mutations.
Small Cell Lung Cancer
Their expertise extends to limited-stage small cell lung cancer (LS-SCLC), focusing on comprehensive treatment approaches for patients with stage I-III disease. The investigator implements integrated therapeutic strategies combining multiple treatment modalities.
- Limited-stage SCLC treatment
- Multimodal therapy approaches
- Combined treatment strategies
Their work incorporates concurrent radiotherapy and chemotherapy protocols enhanced with novel therapeutic agents.
Advanced Oncology
The investigator has significant experience in treating advanced tumors and metastatic disease, particularly focusing on survival outcomes. Their expertise includes managing complex cases requiring sophisticated therapeutic interventions.
- Advanced tumor management
- Metastatic disease treatment
- Long-term survival strategies
They work with various therapeutic combinations including platinum-based chemotherapy and innovative treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.